T-cell therapy – treatment of the future for resistant cancers

Professor Shimon Slavin talks about the history and modern realities of the use of cell therapy for cancer, the different types of immune cells and their application for cancer treatment. As part of the interview, professor Slavin shared the story of his first patient with leukemia, to whom the doctor transplanted donor lymphocytes more than 30 years ago. The treatment gave a positive result, and this person is still alive and well.

The professor also spoke about his experience with the use of donor T-lymphocytes and the author’s developments, which were able to reduce the doses of chemoradiotherapy used and give hope to hundreds of patients of any age for a cure or prolongation of life.